Media release issued by ISSCR
The ISSCR is disappointed with the enactment of the ‘Right to Try’ law. Along with more than 100 patient and research groups opposing the bill, we believe it will put patients at risk and undermine the effective FDA Expanded Access Program already in place to give seriously ill patients access to experimental treatments.
“Instead of helping patients, this law will harm patients by providing a route for snake-oil salesman to evade regulation and sell unproven and scientifically dubious therapies to patients,” said ISSCR President Hans Clevers. “In recent months, several patients have been blinded by clinics administering unproven stem cell interventions for eye disease. The Right to Try bill only emboldens bad actors looking for ways to take advantage of desperate patients,” he said. [Read more…] about ISSCR Responds to President Trump Signing ‘Right to Try’ Law